Edesa Biotech, Inc. (EDSA)
1 Item 5.02 filing since 2026-10-23 · roles: CEO. Nasdaq. Pharmaceutical Preparations.
| Score | Filed | Event | Role | Person | Seat | Summary |
|---|---|---|---|---|---|---|
| 0 | 2026-10-23 | Compensation only | CEO | subscribers | — | Edesa Biotech, Inc. (EDSA): CEO Dr. Pardeep Nijhawan compensation terms |
Executive changes at other companies: all filings · CEO · CFO · How Item 5.02 works